Literature DB >> 11882999

The A17L gene product of vaccinia virus is exposed on the surface of IMV.

K Wallengren1, C Risco, J Krijnse-Locker, M Esteban, D Rodriguez.   

Abstract

The p21 membrane protein of vaccinia virus (VV), encoded by the A17L gene, has been reported to localize on the inner of the two membranes of the intracellular mature virus (IMV). It has also been shown that p21 acts as a membrane anchor for the externally located fusion protein p14 (A27L gene). Since p14 is located on the surface of IMVs, it is hard to envision that p21 should be located only on the inner membrane. Our results from (i) immunoelectron microscopy, (ii) biotinylation, and (iii) protease treatment of purified IMVs showed that the N-terminus of p21 is exposed on the surface of virus particles, while the C-terminus is embedded in the membrane. Mono-specific antibodies to the N-terminus of p21 neutralize infection of VV while antibodies to the C-terminal domain do not. We suggest that p21 molecules are located both in the inner and in the outer membrane of IMV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11882999     DOI: 10.1006/viro.2001.1131

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.

Authors:  D Huw Davies; Sookhee Chun; Gary Hermanson; Jo Anne Tucker; Aarti Jain; Rie Nakajima; Jozelyn Pablo; Philip L Felgner; Xiaowu Liang
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

2.  Vaccinia viral protein A27 is anchored to the viral membrane via a cooperative interaction with viral membrane protein A17.

Authors:  Da-Rong Wang; Jye-Chian Hsiao; Chien-Hsuan Wong; Guo-Chian Li; Su-Ching Lin; Steve S-F Yu; Wenlung Chen; Wen Chang; Der-Lii M Tzou
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

3.  Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid rafts.

Authors:  Che-Sheng Chung; Cheng-Yen Huang; Wen Chang
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.

Authors:  D Huw Davies; Megan M McCausland; Conrad Valdez; Devan Huynh; Jenny E Hernandez; Yunxiang Mu; Siddiqua Hirst; Luis Villarreal; Philip L Felgner; Shane Crotty
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 5.  Smallpox vaccines: targets of protective immunity.

Authors:  Bernard Moss
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

6.  Fine structure of the vaccinia virion determined by controlled degradation and immunolocalization.

Authors:  Nissin Moussatche; Richard C Condit
Journal:  Virology       Date:  2014-12-08       Impact factor: 3.616

7.  Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.

Authors:  Mohammed Rafii-El-Idrissi Benhnia; Megan M McCausland; Hua-Poo Su; Kavita Singh; Julia Hoffmann; D Huw Davies; Philip L Felgner; Steven Head; Alessandro Sette; David N Garboczi; Shane Crotty
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

8.  Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations.

Authors:  M B Townsend; M S Keckler; N Patel; D H Davies; P Felgner; I K Damon; K L Karem
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

9.  Biogenesis of the vaccinia virus membrane: genetic and ultrastructural analysis of the contributions of the A14 and A17 proteins.

Authors:  Bethany Unger; Jason Mercer; Kathleen A Boyle; Paula Traktman
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

10.  Functional characterization of the vaccinia virus I5 protein.

Authors:  Bethany Unger; R Jeremy Nichols; Eleni S Stanitsa; Paula Traktman
Journal:  Virol J       Date:  2008-12-15       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.